Daniel J Landsburg, MD

faculty photo
Assistant Professor of Clinical Medicine
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-161
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-615-7361
Fax: 215-615-5888
Education:
BA
University of Pennsylvania, 2004.
MD
Temple University School of Medicine, 2008.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Non-Hodgkin lymphoma
Hodgkin lymphoma
Autologous stem cell transplantation

Description of Other Expertise

Clinical operations
Quality improvement
Patient safety

Description of Research Expertise

Double-hit B cell lymphoma
MYC-altered B cell lymphoma
Diffuse large B cell lymphoma
Aggressive B cell lymphoma

Selected Publications

Landsburg Daniel J: Advancing the management of double hit lymphoma. Oncotarget 8(45): 78245-78246, Oct 2017.

Winter Allison M, Landsburg Daniel J, Mato Anthony R, Isaac Krista, Hernandez-Ilizaliturri Francisco J, Reddy Nishitha, Smith Stephen, Shadman Mazyar, Smith Mitchell R, Caimi Paolo, Jagadeesh Deepa, Hill Brian T: A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib. Blood Aug 2017.

Landsburg Daniel J, Falkiewicz Marissa K, Maly Joseph, Blum Kristie A, Howlett Christina, Feldman Tatyana, Mato Anthony R, Hill Brian T, Li Shaoying, Medeiros L Jeffrey, Torka Pallawi, Hernandez-Ilizaliturri Francisco, Reddy Nishitha M, Singavi Arun, Fenske Timothy S, Chavez Julio C, Kaplan Jason B, Behdad Amir, Petrich Adam M, Bast Martin A, Vose Julie M, Olszewski Adam J, Costa Cristiana, Lansigan Frederick, Gerson James N, Barta Stefan K, Calzada Oscar, Cohen Jonathon B, Lue Jennifer K, Amengual Jennifer E, Rivera Xavier, Persky Daniel O, Peace David J, Nathan Sunita, Cassaday Ryan D: Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 35(20): JCO2017722157, May 2017.

Landsburg Daniel J, Falkiewicz Marissa K, Petrich Adam M, Chu Benjamin A, Behdad Amir, Li Shaoying, Medeiros L Jeffrey, Cassaday Ryan D, Reddy Nishitha M, Bast Martin A, Vose Julie M, Kruczek Kimberly R, Smith Scott E, Patel Priyank, Hernandez-Ilizaliturri Francisco, Karmali Reem, Rajguru Saurabh, Yang David T, Maly Joseph J, Blum Kristie A, Zhao Weiqiang, Vanslambrouck Charles, Nabhan Chadi: Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable. British journal of haematology 175(4): 631-640, Nov 2016.

Landsburg Daniel J: Management of Patients with MYC-Altered Lymphomas. Current Hematologic Malignancy Reports 11(3): 208-17, Jun 2016.

Landsburg Daniel J, Schuster Stephen J: Who Should Be Tested for Double-Hit Lymphoma? Journal of Oncology Practice/American Society of Clinical Oncology 12(3): 243-4, Mar 2016.

Landsburg Daniel J, Petrich Adam M, Abramson Jeremy S, Sohani Aliyah R, Press Oliver, Cassaday Ryan, Chavez Julio C, Song Kevin, Zelenetz Andrew D, Gandhi Mitul, Shah Namrata, Fenske Timothy S, Jaso Jesse, Medeiros L Jeffrey, Yang David T, Nabhan Chadi: Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma. Cancer 122(4): 559-64, Nov 2015.

Howlett Christina, Snedecor Sonya J, Landsburg Daniel J, Svoboda Jakub, Chong Elise A, Schuster Stephen J, Nasta Sunita Dwivedy, Feldman Tatyana, Rago Allison, Walsh Kristy M, Weber Scott, Goy Andre, Mato Anthony: Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis. British Journal of Haematology 170(4): 504-14, Aug 2015 Notes:

Petrich Adam M, Gandhi Mitul, Jovanovic Borko, Castillo Jorge J, Rajguru Saurabh, Yang David T, Shah Khushboo A, Whyman Jeremy D, Lansigan Frederick, Hernandez-Ilizaliturri Francisco J, Lee Lisa X, Barta Stefan K, Melinamani Shruthi, Karmali Reem, Adeimy Camille, Smith Scott, Dalal Neil, Nabhan Chadi, Peace David, Vose Julie, Evens Andrew M, Shah Namrata, Fenske Timothy, Zelenetz Andrew D, Landsburg Daniel J, Howlett Christina, Mato Anthony, Jaglal Michael, Chavez Julio C, Tsai Judy P, Reddy Nishitha, Li Shaoying, Handler Caitlin, Flowers Christopher R, Cohen Jonathon B, Blum Kristie A, Song Kevin, Sun Haowei Linda, Press Oliver, Cassaday Ryan, Jaso Jesse, Medeiros L Jeffrey, Sohani Aliyah R, Abramson Jeremy S: Impact of induction regimen and stem cell transplantation on outcomes in patients with double hit lymphoma: a large multicenter retrospective analysis. Blood 124(15): 2354-61, Aug 2014.

Landsburg Daniel J, Nasta Sunita D, Svoboda Jakub, Morrissette Jennifer J D, Schuster Stephen J: 'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients. British Journal of Haematology 166(3): 369-74, Apr 2014.

back to top
Last updated: 12/09/2017
The Trustees of the University of Pennsylvania